Table 2 Results of one way analysis of variance (ANOVA) for the DPPH, hypoglycemic/antidiabetic and anti-inflammatory (HRBC membrane stabilization) activity.
Assay | Standard /test | Regression equation | IC50 concentration (μg/ml) | Results of one way analysis of variance (ANOVA) | ||||
|---|---|---|---|---|---|---|---|---|
Parameter | Sum of squares (SS) | Degrees of freedom (df) | Mean square (MS) | F value | ||||
P value with inference | ||||||||
DPPH | Ascorbic acid | y = 2.9068x + 16.826 R2 = 0.9528 | 11.41 | Between groups | 1175.5 | 2 | 587.7 | 2.0 |
FN-CDs | y = 1.8644x + 20.898 R2 = 0.9795 | 15.6 | Within group | 3516.3 | 12 | 293.0 | ||
Z-FN-CDs | y = 1.2442x + 20.097 R2 = 0.9392 | 24.03 | Total | 4691.8 | 14 | – | 0.1 NS | |
Antidiabetic activity | Acarbose | y = 0.1719x + 41.459 R2 = 0.9834 | 49.73 | Between groups | 5870.2 | 2 | 2935.1 | 9.07 |
FN-CDs | y = 0.306x + 1.629 R2 = 0.9449 | 158.07 | Within group | 3882.5 | 12 | 323.5 | ||
Z-FN-CDs | y = 0.1551x + 4.454 R2 = 0.9198 | 293.65 | Total | 9752.8 | 14 | – | 0.0 S | |
HRBC membrane stabilization | Diclofenac | y = 2.8832x + 18.162 R2 = 0.9022 | 11.07 | Between groups | 1724.0 | 2 | 862.0 | 1.8 |
FN-CDs | y = 1.888x + 1.934 R2 = 0.9871 | 22.28 | Within group | 5606.0 | 12 | 467.1 | ||
Z-FN-CDs | y = 2.994x + 10.448 R2 = 0.9336 | 13.21 | Total | 7330.0 | 14 | – | 0.2 NS | |
